Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GSTS Celebrate Success of Inaugural Scientific Symposium and Launch Innovation Academy

Published: Thursday, July 11, 2013
Last Updated: Thursday, July 11, 2013
Bookmark and Share
GSTS recently hosted their first Innovation Academy event in London (28 June 2013).

This inaugural scientific symposium welcomed over 100 attendees, offering participants great networking opportunities and the chance to hear presentations from a group of GSTS experts.

Discussions were focused into four tracks – child health, keeping people healthy, infectious diseases, and next-generation diagnostics – and on-show was the innovative approach to laboratory medicine that can be found throughout the GSTS organisation.

GSTS_Photo.gifDr Dominic Harrington, Scientific Director, and co-chair of the event, said, “Clinical science is part of the fabric of GSTS, and the scientists presenting here today continue to make significant contributions to the further development of best-practice in clinical pathology. The Innovation Academy event allowed us to share, celebrate and support the contributions of our staff. We were delighted to see the turnout on the day and look forward to the next one.”


As the UK's leading independent provider of pathology services, GSTS and King's College Pathology LLP provide pathology services that make a real difference to patient care. The Innovation Academy was organised to create an environment to support innovation, quality and the development of future scientific leaders. Dr Harrington said “Today is about the scientists being heard. We have broken the science into four broad themes to help make potentially higher level science more accessible to the decision makers and executive teams, as well as for our users. This enables us to articulate the value that scientists bring to patients, medics, and to the GSTS organisation.”

Drawing from twelve senior scientists across the GSTS and KingsPath partnership, the presentations covered current trends and topical developments in areas such as expanded newborn screening, vitamin B12 deficiency, HIV drug resistance and pre-implantation genetic diagnosis. Dr Harrington said “Underneath today’s themes is some real high end science and this has come across because, after all, a subject matter expert is always the best person to articulate the enthusiasm for that area”.

Dr Harrington added, “There is currently a direction towards consolidation of laboratory services and this is a challenge, so having an event such as this where the collaboration can come together really helps partners learn and understand each others’ expertise.

The next event in the series is planned for 6th December 2013.

To find out more about innovation at GSTS and KingsPath, please visit: www.gsts.com


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Genetic Diversity of Enzymes Alters Metabolic Individuality
ToMMo scientists have shown that genetic polymorphisms, structural location of mutation and effect for phenotype correlate with each other.
IMM Uses Nanowizard® to Evaluate Cardiovascular Disease Risk
JPK Instruments reports on the use of their NanoWizard® AFM system at the Instituto de Medicina Molecular at the University of Lisbon.
$1M NIH Grant to Refine PCR Based Cancer Test
Researchers at Cornell University, Weill Cornell Medicine, the University of California, San Francisco, and the Infectious Diseases Institute in Kampala, Uganda, recieve a four-year, $1 million grant to hone technology for a quick, in-the-field diagnosis of Kaposi's sarcoma — a cancer frequently related to HIV infections.
Zika Reference Strain Sequenced
An international research team has sequenced a strain of Zika for use as a WHO reference strain.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!